Royal Bank Of Canada G1 Therapeutics, Inc. Transaction History

Royal Bank Of Canada

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.2 - $4.98 $10,159 - $22,997	4,618 Added 19241.67%	4,642 $10,000
Q1 2024 Nov 05, 2024	SELL	$2.1 - $4.83 $9,697 - $22,304	-4,618 Reduced 99.48%	24 $0
Q1 2024 May 15, 2024	SELL	$2.1 - $4.83 $138 - $318	-66 Reduced 73.33%	24 $0
Q3 2023 Nov 14, 2023	SELL	$1.22 - $2.67 $896 - $1,962	-735 Reduced 89.09%	90 $0
Q2 2023 Aug 14, 2023	BUY	$2.46 - $3.14 $366 - $467	149 Added 22.04%	825 $2,000
Q1 2023 May 15, 2023	SELL	$2.57 - $8.16 $1,927 - $6,120	-750 Reduced 52.59%	676 $1,000
Q4 2022 Feb 14, 2023	SELL	$5.19 - $13.5 $1,074 - $2,794	-207 Reduced 12.68%	1,426 $7,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $6,390 - $20,999	1,236 Added 311.34%	1,633 $21,000
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $9,712 - $20,458	-2,404 Reduced 85.83%	397 $1,000
Q1 2022 May 16, 2022	SELL	$7.6 - $11.02 $46,040 - $66,759	-6,058 Reduced 68.38%	2,801 $22,000
Q4 2021 Feb 14, 2022	BUY	$10.16 - $16.17 $36,626 - $58,292	3,605 Added 68.61%	8,859 $91,000
Q3 2021 Nov 15, 2021	BUY	$13.16 - $22.47 $28,228 - $48,198	2,145 Added 68.99%	5,254 $71,000
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $60,843 - $81,828	3,109 New	3,109 $69,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.